Alistair Irvine
Keine laufenden Positionen mehr
Profil
Alistair Irvine worked as Deputy Director-Operations & Research at Innovata Ltd., Head-Biology at ML Laboratories Plc, Senior Scientist at Cobra Therapeutics Ltd., and Chief Business Officer at Kuros Biosurgery Holding AG and Kuros Biosciences Ltd.
He received an undergraduate degree from The University of Edinburgh and a doctorate degree from The University of Sheffield.
Ehemalige bekannte Positionen von Alistair Irvine
| Unternehmen | Position | Ende |
|---|---|---|
| KUROS BIOSCIENCES AG | Corporate Officer/Principal | 01.02.2023 |
Cobra Therapeutics Ltd.
 Cobra Therapeutics Ltd. Medical SpecialtiesHealth Technology Cobra Therapeutics Ltd. manufactured cancer therapeutics on contract basis. It also developed gene delivery and expression technologies. The company was founded in 1992 and was headquartered in Keele, UK | Technik-/Wissenschafts-/F&E-Leiter | - |
Innovata Ltd.
 Innovata Ltd. Pharmaceuticals: MajorHealth Technology Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom. | Geschäftsführer | - |
| ML Laboratories Plc | Corporate Officer/Principal | - |
Kuros Biosurgery Holding AG
 Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosurgery Holding AG operated as a medical technology company. It engaged in the development of biologic and biomaterial-based product candidates for localized therapy in trauma, spine and wound care. The company was founded by Marion Bavand, Didier Cowling, Dominik Ellenrieder, and Jeffrey Hubbel on April 3, 2008 and was headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - |
Ausbildung von Alistair Irvine
| The University of Edinburgh | Undergraduate Degree |
| The University of Sheffield | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KUROS BIOSCIENCES AG | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| ML Laboratories Plc | Commercial Services |
Kuros Biosurgery Holding AG
Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosurgery Holding AG operated as a medical technology company. It engaged in the development of biologic and biomaterial-based product candidates for localized therapy in trauma, spine and wound care. The company was founded by Marion Bavand, Didier Cowling, Dominik Ellenrieder, and Jeffrey Hubbel on April 3, 2008 and was headquartered in Zurich, Switzerland. | Commercial Services |
Cobra Therapeutics Ltd.
Cobra Therapeutics Ltd. Medical SpecialtiesHealth Technology Cobra Therapeutics Ltd. manufactured cancer therapeutics on contract basis. It also developed gene delivery and expression technologies. The company was founded in 1992 and was headquartered in Keele, UK | Health Technology |
Innovata Ltd.
Innovata Ltd. Pharmaceuticals: MajorHealth Technology Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
